Underground To Mainstream

Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution

  • Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distribution
  • Adds Filament’s extensive intellectual property portfolio, including 70+ patents and proprietary extraction technologies
  • Leverages Health Canada Dealer’s License and FDA-aligned clinical development pathways, including IND-enabled activities
  • Positions the Company at the forefront of the rapidly emerging regulated psychedelic medicine industry
  • Advances clinical pipeline, including PEX010, while expanding access to natural psilocybin products globally
  • Establishes a regulated pipeline of psychedelic compounds, including ibogaine, MDMA, and psilocybin, supporting next-generation drug discovery and IND-enabled clinical development within compliant frameworks
Learn More About Filament Health

CSE: TRIP | FSE: 4YX | OTC: TRUFF

Red Light Holland Icon
Scarlette Lillie Science and Innovation
Red Light Health Icon

Scarlette Lillie Science and Innovation

Red Light Holland recently signed a definitive agreement to acquire Mera Life Sciences (“Mera”). Upon closing of the transaction, Mera will be renamed to Scarlette Lillie Sciences and Innovation and will serve as the company’s applied science platform. Mera currently holds a Medicinal Industry Development License issued by the St. Vincent and the Grenadines Bureau of Standards, which permits the research, cultivation, production, development and extraction, import and export, clinical treatment facilities, and prescribed patient access in specifically licensed clinical treatment facilities for medicinal purposes and scientific research only. The License applies to the following compounds: Turmeric, Aloe Vera, Papaya, Arrowroot, Soursop, Coconut, Ginger, Moringa, Ayahuasca, Mushroom, Iboga, Sassafras, Peyote, Psilocybin, Ibogaine, Dimethyltryptamine (DMT), Mescaline, Ketamine, 3-4 Methylenedioxy – Methamphetamine (MDMA), Lysergic Acid Diethylamide (LSD), 5-Methoxy-N,N-Dimethyltrypotomine (5-MeO-DMT).

Red Light Rec

Red Light Rec

Red Light Rec is a supplier of premium magic truffles to the legal, recreational adult use market in the Netherlands.

Red Light Health

Red Light Health

Red Light Health’s goal is to supply the Medical Market with naturally occurring, non-synthetic psilocybin, as current clinical trials are using a synthetic psychedelic prodrug compound. We believe in the entourage effect of ‘whole fungi’ medicine and expect to be the first company to have the capability to grow in order to help discover and benefit off the entire psilocybin Truffle.

Red Light Holland

Red Light Holland

Red Light Rec is a supplier of premium magic truffles to the legal, recreational adult use market in the Netherlands.

Red Light Holland featured on the Joe Rogan Experience.

Red Light Holland’s goal is to, over time, help make the relatively unknown ‘magic truffle’ a familiar name across the world. We currently grow, distribute and market a premium brand of magic truffles to the legal, recreational market within the Netherlands, and we can't wait to shift the existing paradigm to direct further attention to the legal and responsible use of magic truffles.

Todd ShapiroCEO, Red Light Holland

Our core business revolves around the production, growth and sale of truffle products in clearly defined legal markets.

Learn MoreResearch Regarding Health Benefits of Mushrooms

Whole Fungi Medicine

Scarlette Lillie Science and Innovation plans on initiating and partnering with medical professionals to help further study the health benefits of ‘whole fungi’ medicine.

Netherland’s Based

Strategically based in the Netherlands, Red Light Holland provides premium, iMicrodose branded truffles to the legal, Dutch adult-use market.

Premium Brand

Red Light Holland produces and distributes a premium brand of responsible consumption focused truffles, with a careful focus on quality.

Stay Up To Date With Our Latest Developments

Visit Investor Center